Research Center: University of Missouri
Location: This study can be conducted either virtually or in person
Lead Researchers: Mary Beth Miller, PhD, and Brett Froeliger, PhD

Chronic sleep difficulties like insomnia are common among adults who use opioids, and unfortunately, there are limited treatment options that don’t involve more medication.

This research study is testing a non-medication treatment – Cognitive Behavioral Therapy for Insomnia (CBT-I) – to understand how it may help people who use opioids improve their sleep, mood, and overall well-being.

Participants will work one-on-one with a trained sleep coach for five weeks (via Zoom). Please note that there will be a camera-on requirement during participation. You’ll also complete brief online surveys and daily sleep diaries. The full study lasts about 7 weeks, and participants will be compensated for their time. Sign up to learn more!

• Participants of this study will receive the gold standard treatment for insomnia: Cognitive Behavioral Therapy.
• Participants will be contributing valuable information that may benefit those with insomnia in the future.
• Participants will be helping to advance medical research.
• Participants will be compensated for assessments. Compensation will only be provided after successful participation.

• You will receive a detailed outline of the study, including treatment, risks, and procedures, and you will be given the chance to ask study staff questions before you decide whether to participate.
• If you decide to participate in the study and later feel that you no longer wish to be part of it, you can withdraw at any time
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.

• Men and women aged 18+ who are experiencing insomnia
• Must live within 60 miles of Columbia, MO
• Must have used opioids (prescribed or illicit)
• Must be able to participate in the study over 7-9 weeks

University of Missouri-Columbia
The University of Missouri–Columbia (Mizzou) is a leading public research university and R1 institution known for its strong programs in health, agriculture, engineering, and nuclear science. Home to the nation’s most powerful university research reactor, Mizzou supports interdisciplinary research across over 100 centers and institutes.